Agree. OM will be the biggest catalyst in Q4 '15 / Q1 '16. I'm really hoping that the P2 trial will turn into P3. Kepivance only enrolled 120 patients for P3. I expect the same for B. So P3 shouldn't take more than one year to complete.

Quote:

---

Also, if B works for ABSSSI and OM, the odds are VERY good that it will work for some (perhaps many) other indications as well.

---